Skip to content. | Skip to navigation

European Coalition on Homeopathic & Anthroposophic Medicinal Products


EU market for homeopathic and anthroposophic medicines grows by over 6% a year

The market for homeopathic and anthroposophic medicinal products in the EU is growing by 6.5% a year according to new figures from ECHAMP, the European Coalition on Homeopathic and Anthroposophic Medicinal Products. It is now valued at €1.24 billion per year; this represents 7% of the total EU market for non-prescription products.

ECHAMP’s new report, ‘Homeopathic and Anthroposophic Medicinal Products in the EU – Profile of an industry 2015,’ the only source for EU-wide data on this sector, provides a comprehensive review of the sector, identifying specific trends, and, for the first time, profiling in detail this unique industry.

The report demonstrates significant to high and growing demand for these products in at least two thirds of EU Member States, including those both with and without a long-term tradition for these products. In some markets, the products are used by up to 60% of the population.

Europe is the global centre of expertise for the manufacture of these products, producing 100 million units of finished products each year. The companies require sophisticated technical expertise to meet complex quality requirements, managing a huge and diverse portfolio of over 1.5 million distinct medicinal products. In order to meet the therapeutic requirements of the sector, products may be both profitable or often low- or no-profit ‘service’ products, resulting in innovative entrepreneurial models. These products have a negligible impact on the environment.

Christiaan Mol, General Secretary of ECHAMP, presents this new data for the industry, saying, “This growing industry is unique and complex and these products add value to the lives of millions of European citizens. However, in order to continue to meet the demands of users, the industry urgently needs more appropriate regulatory governance that take its specific characteristics into due account.”

Copies of the new report can be downloaded from ECHAMP’s website:

Notes for editors

  1. ECHAMP is the European association of companies that works to develop the industry for homeopathic and anthroposophic medicinal products so that its members can meet the demand from users and prescribers across the EU for homeopathic and anthroposophic medicinal products. It advocates in favour of an appropriate regulatory environment for these products in the EU.
  2. Homeopathy and anthroposophic medicine are widely used in Europe and other parts of the world and have been for decades. Three out of four Europeans know about homeopathy and of these 29% use it for their health care - over 100 million European citizens use over-the-counter or prescribed homeopathic medicines.
  3. Homeopathic and anthroposophic medicines cover a broad portfolio of products mostly derived from natural substances; they have a proven positive safety profile and are part of a long-standing European therapeutic tradition that continues to grow in popularity with patients, doctors and practitioners.
  4. ECHAMP’s new report, ‘Homeopathic and Anthroposophic Medicinal Products in the EU – Profile of an industry 2015,’ draws its data from publicly available statistics and data, market studies, published and peer-reviewed research, ECHAMP partners and other stakeholders, and from a detailed survey of ECHAMP Full Members, the companies who manufacture and distribute these products in the EU.


Last updated on 16 Dec 2015